Keswadee Lapphra

918 total citations
53 papers, 632 citations indexed

About

Keswadee Lapphra is a scholar working on Infectious Diseases, Epidemiology and Virology. According to data from OpenAlex, Keswadee Lapphra has authored 53 papers receiving a total of 632 indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Infectious Diseases, 25 papers in Epidemiology and 10 papers in Virology. Recurrent topics in Keswadee Lapphra's work include HIV/AIDS drug development and treatment (11 papers), HIV/AIDS Research and Interventions (11 papers) and HIV Research and Treatment (10 papers). Keswadee Lapphra is often cited by papers focused on HIV/AIDS drug development and treatment (11 papers), HIV/AIDS Research and Interventions (11 papers) and HIV Research and Treatment (10 papers). Keswadee Lapphra collaborates with scholars based in Thailand, United States and Canada. Keswadee Lapphra's co-authors include Kulkanya Chokephaibulkit, Wanatpreeya Phongsamart, Sutee Yoksan, David W. Scheifele, Orasri Wittawatmongkol, Chukiat Sirivichayakul, Krisana Pengsaa, Pornthep Chanthavanich, Linda Huh and Tipa Chakorn and has published in prestigious journals such as PLoS ONE, The Journal of Infectious Diseases and The Lancet Infectious Diseases.

In The Last Decade

Keswadee Lapphra

50 papers receiving 609 citations

Peers

Countries citing papers authored by Keswadee Lapphra

Since Specialization

Citations

This map shows the geographic impact of Keswadee Lapphra's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Keswadee Lapphra with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Keswadee Lapphra more than expected).

Fields of papers citing papers by Keswadee Lapphra

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Keswadee Lapphra. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Keswadee Lapphra. The network helps show where Keswadee Lapphra may publish in the future.

Co-authorship network of co-authors of Keswadee Lapphra

This figure shows the co-authorship network connecting the top 25 collaborators of Keswadee Lapphra. A scholar is included among the top collaborators of Keswadee Lapphra based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Keswadee Lapphra. Keswadee Lapphra is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Immunogenicity and safety of the live-attenuated tetravalent dengue vaccine (TAK-003) co-administered with recombinant 9-valent human papillomavirus vaccine 2025 ·Vaccine ·(unknown), Suvaporn Anugulruengkitt, Keswadee Lapphra, Kriengsak Limkittikul, Auchara Tangsathapornpong, (unknown), Michael Hellwig, (unknown), Ron P. Schuring, Shibadas Biswal, Nicolas Folschweiller	0
2	In‐host modeling of dengue virus and non‐structural protein 1 and the effects of ivermectin in patients with acute dengue fever 2024 ·CPT Pharmacometrics & Systems Pharmacology ·Junjie Ding, (unknown), (unknown), Chunya Puttikhunt, Sansanee Noisakran, (unknown), Adisak Songjaeng, (unknown), Nattaya Tangthawornchaikul, Nasikarn Angkasekwinai, (unknown), Keswadee Lapphra, Kulkanya Chokephaibulkit, Nicholas J. White, Panisadee Avirutnan, Joel Tärning	0
3	Case Report: Reemerging Paragonimiasis in Umphang District, Thailand 2023 ·American Journal of Tropical Medicine and Hygiene ·(unknown), Keswadee Lapphra, (unknown), (unknown), (unknown), Kulkanya Chokephaibulkit	5
4	Effective and safe transfer of maternal antibodies persisting two months postpartum following maternal immunization with different doses of recombinant pertussis-containing vaccines 2023 ·Vaccine ·Kulkanya Chokephaibulkit, Thanyawee Puthanakit, Surasith Chaithongwongwatthana, Niranjan Bhat, Yuxiao Tang, Suvaporn Anugulruengkitt, (unknown), (unknown), Keswadee Lapphra, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Phạm Hồng Thái, Bruce L. Innis	7
5	A phase 2 randomized controlled dose-ranging trial of recombinant pertussis booster vaccines containing genetically inactivated pertussis toxin in pregnant women 2023 ·Vaccine ·Thanyawee Puthanakit, Kulkanya Chokephaibulkit, Surasith Chaithongwongwatthana, Niranjan Bhat, Yuxiao Tang, Suvaporn Anugulruengkitt, (unknown), (unknown), Keswadee Lapphra, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Phạm Hồng Thái, Bruce L. Innis	7
6	Depression and Anxiety in Youth and Young Adults Living with HIV: Frequency and Associated Factors in Thai Setting 2022 ·Journal of the International Association of Providers of AIDS Care (JIAPAC) ·(unknown), (unknown), (unknown), Keswadee Lapphra, (unknown), (unknown), Orasri Wittawatmongkol, Wanatpreeya Phongsamart, (unknown), (unknown), Kulkanya Chokephaibulkit	10
7	Immunogenicity and safety profiles of a new MAV/06 strain varicella vaccine in healthy children: A multinational, multicenter, randomized, double-blinded, active-controlled phase III study 2021 ·Vaccine ·Ui Yoon Choi, Ki Hwan Kim, Jin Lee, Byung Wook Eun, Dong Ho Kim, (unknown), Chun Soo Kim, Keswadee Lapphra, Auchara Tangsathapornpong, Pope Kosalaraksa, Peninnah Oberdorfer, Hwang Min Kim, Son Moon Shin, Jin Han Kang	6
8	Clinical features and outcomes of Bacille Calmette-Guérin (BCG)-induced diseases following neonatal BCG Tokyo-172 strain immunization 2018 ·Vaccine ·(unknown), (unknown), (unknown), (unknown), Orasri Wittawatmongkol, Keswadee Lapphra, Wanatpreeya Phongsamart, (unknown), (unknown), Kulkanya Chokephaibulkit	20
9	Human parvovirus B19 nosocomial outbreak in healthcare personnel in a paediatric ward at a national tertiary referral centre in Thailand 2017 ·Journal of Hospital Infection ·(unknown), Wanatpreeya Phongsamart, (unknown), Keswadee Lapphra, Orasri Wittawatmongkol, (unknown), (unknown), (unknown), (unknown), Nattawat Onlamoon, Navin Horthongkham, (unknown), (unknown), Kulkanya Chokephaibulkit	2
10	Immunogenicity of a Live Attenuated Chimeric Japanese Encephalitis Vaccine as a Booster Dose After Primary Vaccination With Live Attenuated SA14-14-2 Vaccine 2016 ·The Pediatric Infectious Disease Journal ·Sirintip Sricharoenchai, Keswadee Lapphra, (unknown), Wanatpreeya Phongsamart, Alain Bouckenooghe, Orasri Wittawatmongkol, (unknown), Kulkanya Chokephaibulkit	5
11	Drug-resistant tuberculosis in children in Thailand 2013 ·The International Journal of Tuberculosis and Lung Disease ·Keswadee Lapphra, (unknown), Suporn Foongladda, Nirun Vanprapar, Wanatpreeya Phongsamart, Orasri Wittawatmongkol, (unknown), Kulkunya Chokephaibulkit	12
12	Prevalence of Vitamin D Deficiency Among Perinatally HIV-infected Thai Adolescents Receiving Antiretroviral Therapy 2013 ·The Pediatric Infectious Disease Journal ·Kulkanya Chokephaibulkit, (unknown), Torsak Bunupuradah, (unknown), Wanatpreeya Phongsamart, Keswadee Lapphra, (unknown), Thanyawee Puthanakit	19
13	Drug-resistant Tuberculosis 2011 ·The Pediatric Infectious Disease Journal ·Mona Al-Dabbagh, Keswadee Lapphra, (unknown), (unknown), H. Simon Schaaf, Ben J. Marais, Laura Sauvé, Ian Kitai, Tobias R. Kollmann	38
14	ADVERSE NEUROLOGIC REACTIONS AFTER BOTH DOSES OF PANDEMIC H1N1 INFLUENZA VACCINE WITH OPTIC NEURITIS AND DEMYELINATION 2010 ·The Pediatric Infectious Disease Journal ·Keswadee Lapphra, Linda Huh, David W. Scheifele	34
15	Acceptability of Internet adverse event self-reporting for pandemic and seasonal influenza immunization among health care workers 2010 ·Vaccine ·Keswadee Lapphra, Simon Dobson, Julie A. Bettinger	10
16	Vaccination site reaction or bacterial cellulitis? 2009 ·Paediatrics & Child Health ·Keswadee Lapphra, David W. Scheifele	7
17	Does vaccination with the varicella vaccine within four weeks after the measles, mumps and rubella vaccine reduce protection? 2009 ·Paediatrics & Child Health ·Keswadee Lapphra, David W. Scheifele	1
18	Efficacy and tolerability of nevirapine- versus efavirenz-containing regimens in HIV-infected Thai children 2008 ·International Journal of Infectious Diseases ·Keswadee Lapphra, Nirun Vanprapar, Sanay Chearskul, Wanatpreeya Phongsamart, (unknown), Wasana Prasitsuebsai, Kulkanya Chokephaibulkit	20
19	AGE-SPECIFIC PREVALENCE OF DENGUE ANTIBODIES IN BANGKOK INFANTS AND CHILDREN 2008 ·The Pediatric Infectious Disease Journal ·Krisana Pengsaa, Kriengsak Limkittikul, Christine Luxemburger, Sutee Yoksan, Laurent Chambonneau, (unknown), Keswadee Lapphra, Pornthep Chanthavanich, Jean Lang, Arunee Sabchareon	14
20	Dengue Virus Infections in the First 2 Years of Life and the Kinetics of Transplacentally Transferred Dengue Neutralizing Antibodies in Thai Children 2006 ·The Journal of Infectious Diseases ·Krisana Pengsaa, Christine Luxemburger, Arunee Sabchareon, Kriengsak Limkittikul, Sutee Yoksan, Laurent Chambonneau, (unknown), Chukiat Sirivichayakul, Keswadee Lapphra, Pornthep Chanthavanich, Jean Lang	44

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact